Jim Cramer Says Buy Uber, Calls Rockwell Automation 'One Ugly Chart' but a 'Great Long-Term Situation' -

Benzinga
Öffnen unter Benzinga

On CNBC’s “ Mad Money Lightning Round ,” Jim Cramer recommended buying Uber Technologies, Inc. (NYSE: UBER ), adding that it is one “ great long-term” stock .

According to recent news, Uber and drone delivery company Zipline announced a strategic partnership on Monday to expand autonomous delivery across the U.S.

Cramer recommended buying Tanger Inc. (NYSE: SKT ), saying it is good. “I saw a recommendation today of taking a price target from $45 to $46 for this $38 stock. It yields 3.25%,” he added.

Lending support to his choice, Tanger, on Aug. 4, posted better-than-expected second-quarter results.

Rockwell Automation, Inc. (NYSE: ROK ) is “high, but it’s more robotics than it is data center, and I think it’s a great long-term situation. So, I would say it’s a good idea, but don’t buy it all at once because the stock is one ugly chart,” Cramer said.

Latest Private Market Opportunities Join 400,000+ Investors

The company, on Aug. 4, reported third-quarter adjusted earnings of $3.49 per share, up 22% from a year earlier and above the analyst consensus estimate of $3.38. Revenue increased 8% year over year to $2.313 billion, beating estimates of $2.243 billion.

When asked about Amcor plc (NYSE: AMCR ), he said, “I’m never going to fight anyone on 10 times earnings. But remember, they also have a kind of a non-fast-growing part of their business, and therefore there are issues, but not a lot that can’t be solved by that low PE.”

On the earnings front, Amcor posted better-than-expected earnings for the fourth quarter on Aug. 12.

Cramer said Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) is fine because it’s profitable. “Although I know that neurological issues are very hard, very tough. Most doctors, hospitals, medical companies don’t want to touch it, but I will say Neurocrine does good job,” he added.

Morgan Stanley analyst Jeffrey Hung, on Aug. 13, maintained an Equal-Weight rating on Neurocrine Biosciences and lowered the price target from $196 to $182.

Price Action:

Uber shares fell 1.3% to settle at $74.99 on Monday. Tanger shares slipped 0.1% to close at $38.41 during the session. Rockwell Automation fell 0.8% to settle at $444.60 on Monday. Neurocrine Biosciences shares gained 1.2% to close at $154.49. Amcor shares fell 1.1% to settle at $45.53 on Monday.

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here .


Posted In: Markets Media Trading Ideas Long Ideas News Jim Cramer Mad Money Lightning Round CNBC .bz3-youtube-box-container { max-width: 360px; margin-bottom: 14px; } .bz3-youtube-box-container .section-block-header { display: none; }